Adequan® Canine is honored to partner with Canine Companions® , the leading organization that provides highly trained service dogs at no charge to people with disabilities. These remarkable dogs help the people they serve live with greater independence.

Adequan® Canine is an FDA-approved injectable treatment for non‑infectious degenerative and traumatic arthritis in dogs. Its active ingredient, polysulfated glycosaminoglycan (PSGAG), helps restore joint health by reducing inflammation and slowing cartilage deterioration. Administered intramuscularly twice a week for up to four weeks,

Adequan offers a science-based way to support your dog’s mobility and long-term joint function.